Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals

Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals

<p>Abstract</p> <p>Background</p> <p>Sildenafil is a cyclic guanosine monophosphate-specific phosphodiesterase-5 inhibitor used for treating pulmonary hypertension. Although the use of sildenafil in patients under 18 years old is off-label, this inhibitor has been widel...

Full description

Bibliographic Details
Main Authors:	Cabral Lucio M, de Souza Ana HA, Huf Gisele
Format:	Article
Language:	English
Published:	BMC 2009-03-01
Series:	BMC Research Notes
Online Access:	http://www.biomedcentral.com/1756-0500/2/30

Similar Items

Sildenafil in the treatment of pulmonary hypertension
by: O. S. Groznova, et al.
Published: (2016-03-01)

Sildenafil in the treatment of pulmonary hypertension
by: Christopher F Barnett, et al.
Published: (2006-12-01)

The effect of sildenafil on the pulmonary artery hypertension caused by Mustard gas
by: Parya Tavakolipour, et al.
Published: (2008-12-01)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
by: Yi Tang, et al.
Published: (2022-04-01)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
by: Gautam V Ramani, et al.
Published: (2010-05-01)

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
by: Oktavia Lilyasari, et al.
Published: (2019-08-01)

In Silico studies of novel Sildenafil self-emulsifying drug delivery system absorption improvement for pulmonary arterial hypertension
by: BARBÁRA A. ABRAHIM-VIEIRA, et al.
Published: (2020-08-01)

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension
by: Oleksandr Valentynovych Oliynyk, et al.
Published: (2023-05-01)

Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension
by: Su-jin Rhee, et al.
Published: (2022-05-01)

Update on pulmonary arterial hypertension in children: management strategies and clinical utility of sildenafil
by: Wardle A, et al.
Published: (2012-08-01)

Lower doses of bosentan in combination with sildenafil might be beneficial in pulmonary arterial hypertension
by: Ahmad Amin, et al.
Published: (2015-01-01)

Comparison of ambrisentan with sildenafil in congenital heart disease with irreversible pulmonary artery hypertension
by: P.M. Raut, et al.
Published: (2014-11-01)

Sildenafil no tratamento da hipertensão arterial pulmonar idiopática em crianças e adolescentes Sildenafil in the management of idiopathic pulmonary arterial hypertension in children and adolescents
by: Edmundo Clarindo Oliveira, et al.
Published: (2005-10-01)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
by: Daniella Aparecida Godoi Kemper, et al.
Published: (2023-07-01)

Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca Sildenafil for pulmonary hypertension treatment after cardiac surgery
by: Maria Regina Bentlin, et al.
Published: (2005-04-01)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
by: Shine Kumar, et al.
Published: (2022-10-01)

One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
by: A.C. Barreto, et al.
Published: (2005-02-01)

Sildenafil citrate therapy for secondary pulmonary arterial hypertension due to chronic obstructive lung disease
by: Khaled Alkhayat, et al.
Published: (2016-10-01)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
by: Kacie Dillon, et al.
Published: (2023-08-01)

Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
by: Lukas Schroeder, et al.
Published: (2023-05-01)

CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2015-12-01)

Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis
by: Marisa van der Graaf, et al.
Published: (2019-08-01)

Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
by: Stephanie Leigh Siehr, et al.
Published: (2015-03-01)

Effectiveness of sildenafil in pulmonary hypertension secondary to mitral valve disease
by: Tinni Mitra, et al.
Published: (2020-01-01)

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
by: Anne M Keogh, et al.
Published: (2008-10-01)

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01)

Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension
by: Nura A. Mohamed, et al.
Published: (2021-02-01)

Comparison of the Efficacy of Milrinone Injection versus Milrinone Plus Oral Sildenafil in Newborns with Pulmonary Arterial Hypertension
by: Mohammad Mehdi Bagheri, et al.
Published: (2021-01-01)

Effect of sildenafil on clinical evidence and hemodynamic parameters in patients with pulmonary arterial hypertension, associated withsystemic rheumaticdiseases
by: A V Volkov, et al.
Published: (2014-09-01)

Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
by: A V Volkov, et al.
Published: (2015-11-01)

Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
by: Nathan J. Verlinden, et al.
Published: (2020-12-01)

Hipertensão arterial pulmonar: fisiopatologia, aspectos genéticos e resposta ao uso crônico do sildenafil Pulmonary arterial hypertension: physiopathology, genetic aspects and response to the chronic use of sildenafil
by: Alessandra Costa Barreto, et al.
Published: (2005-08-01)

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-06-01)

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
by: Maurice Beghetti, et al.
Published: (2017-07-01)

Short term effects of sildenafil citrate therapy in secondary pulmonary hypertension
by: Mohamed Salem, et al.
Published: (2014-03-01)

The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension
by: Z Kh Dadacheva, et al.
Published: (2015-09-01)

Efficacy, safety and tolerability of sildenafil in Brazilian hypertensive patients on multiple antihypertensive drugs
by: Denilson C. Albuquerque, et al.
Published: (2005-08-01)

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
by: Berger Ariel, et al.
Published: (2012-12-01)

Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway
by: Yaolu Zhu, et al.
Published: (2021-01-01)

Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure
by: Kinjal Desai, et al.
Published: (2023-01-01)